DK424188A - Thrombin-koagulerbare proteiner og fremgangsmaade til deres fremstilling - Google Patents

Thrombin-koagulerbare proteiner og fremgangsmaade til deres fremstilling

Info

Publication number
DK424188A
DK424188A DK424188A DK424188A DK424188A DK 424188 A DK424188 A DK 424188A DK 424188 A DK424188 A DK 424188A DK 424188 A DK424188 A DK 424188A DK 424188 A DK424188 A DK 424188A
Authority
DK
Denmark
Prior art keywords
thrombin
preparation
procedures
proteins
concentrate
Prior art date
Application number
DK424188A
Other languages
English (en)
Other versions
DK424188D0 (da
DK173568B1 (da
Inventor
Myriana Burnouf
Thierry Burnouf
Original Assignee
Centre Regional De Transfusion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Regional De Transfusion filed Critical Centre Regional De Transfusion
Publication of DK424188D0 publication Critical patent/DK424188D0/da
Publication of DK424188A publication Critical patent/DK424188A/da
Application granted granted Critical
Publication of DK173568B1 publication Critical patent/DK173568B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK198804241A 1987-07-30 1988-07-29 Fremgangsmåde til fremstilling af et plasmabaseret, thrombinkoagulerbart proteinkoncentrat samt herved opnåede proteinkonce DK173568B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8710798 1987-07-30
FR8710798A FR2618784B1 (fr) 1987-07-30 1987-07-30 Concentre de proteines coagulables par la thrombine, son procede d'obtention et son utilisation a titre de colle biologique

Publications (3)

Publication Number Publication Date
DK424188D0 DK424188D0 (da) 1988-07-29
DK424188A true DK424188A (da) 1989-01-31
DK173568B1 DK173568B1 (da) 2001-03-19

Family

ID=9353711

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198804241A DK173568B1 (da) 1987-07-30 1988-07-29 Fremgangsmåde til fremstilling af et plasmabaseret, thrombinkoagulerbart proteinkoncentrat samt herved opnåede proteinkonce

Country Status (10)

Country Link
EP (1) EP0305243B1 (da)
JP (1) JP2787317B2 (da)
AT (1) ATE73341T1 (da)
CA (1) CA1341376C (da)
DE (1) DE3869018D1 (da)
DK (1) DK173568B1 (da)
ES (1) ES2039666T3 (da)
FR (1) FR2618784B1 (da)
GR (1) GR3004047T3 (da)
NO (1) NO174929C (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0431072Y2 (da) * 1988-03-14 1992-07-27
FR2639958B1 (fr) * 1988-12-06 1992-08-21 Lille Transfusion Sanguine Support biologique pour cultures cellulaires constitue de proteines plasmatiques coagulees par la thrombine, son utilisation pour la culture des keratinocytes, leur recuperation et leur transport a des fins d'utilisation therapeutique
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6197325B1 (en) 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6117425A (en) 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
US7229959B1 (en) 1990-11-27 2007-06-12 The American National Red Cross Supplemented fibrin matrix delivery systems
DE4202667C1 (da) * 1992-01-29 1993-05-13 Behringwerke Ag, 3550 Marburg, De
WO1994002183A1 (en) * 1992-07-27 1994-02-03 Haemacure Biotech Inc. Biocompatible surgical implant
FR2696095B1 (fr) * 1992-09-30 1994-11-25 Inoteb Colle biologique à base de protéines coagulables par la thrombine, enrichie en facteurs plaquettaires, sa préparation et son application.
US5290918A (en) * 1993-02-23 1994-03-01 Haemacure Biotech Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by acidic precipitation
US5395923A (en) * 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"
US5980866A (en) * 1996-03-15 1999-11-09 Juridical Foundation The Chemosero-Therapeutic Research Institute Tissue adhesive suitable for spray application
WO1998055140A1 (en) * 1997-06-05 1998-12-10 Omrix Biopharmaceuticals S.A. Fibrinogen concentrate from human plasma
GB0216001D0 (en) 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
US20060019234A1 (en) * 2004-07-22 2006-01-26 Shanbrom Technologies, Llc Modern blood banking employing improved cell preservation composition
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
FR2894831B1 (fr) 2005-12-16 2008-02-15 Lab Francais Du Fractionnement Colle biologique exempte de thrombine et son utilisation comme medicament.
FR2952641B1 (fr) 2009-11-18 2012-01-13 Lfb Biomedicaments Procede de traitement du plasma sanguin comprenant une etape de lavage par dispersion
FR3032621A1 (fr) 2015-02-13 2016-08-19 Lab Francais Du Fractionnement Colle biologique et son utilisation comme medicament
WO2016198641A1 (en) 2015-06-12 2016-12-15 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Injectable composition of factor vii and fillers

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156681A (en) * 1974-03-28 1979-05-29 Plasmesco Ag Process for isolating albumin from blood
AT359652B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
AT359653B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
DE3171072D1 (en) * 1981-06-25 1985-07-25 Stroetmann M Serapharm Enriched plasma derivative for promoting wound sealing and wound covering
US4374061A (en) * 1981-07-27 1983-02-15 Center For Blood Research, Inc. Means and methods for purifying Clq, Clr and Cls
DE3203775A1 (de) * 1982-02-04 1983-08-11 Behringwerke Ag, 3550 Marburg Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung
DE3228502A1 (de) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung des c1-inaktivators und seine verwendung
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
US4613501A (en) * 1984-12-21 1986-09-23 New York Blood Center, Inc. Inactivation of viruses in labile blood derivatives

Also Published As

Publication number Publication date
NO174929C (no) 1994-08-03
DE3869018D1 (de) 1992-04-16
FR2618784B1 (fr) 1990-04-06
EP0305243A1 (fr) 1989-03-01
DK424188D0 (da) 1988-07-29
GR3004047T3 (da) 1993-03-31
ES2039666T3 (es) 1993-10-01
JP2787317B2 (ja) 1998-08-13
EP0305243B1 (fr) 1992-03-11
FR2618784A1 (fr) 1989-02-03
NO174929B (no) 1994-04-25
CA1341376C (fr) 2002-07-16
DK173568B1 (da) 2001-03-19
JPH02114A (ja) 1990-01-05
NO883342D0 (no) 1988-07-28
NO883342L (no) 1989-01-31
ATE73341T1 (de) 1992-03-15

Similar Documents

Publication Publication Date Title
DK424188D0 (da) Thrombin-koagulerbare proteiner og fremgangsmaade til deres fremstilling
DE3876401D1 (de) N-terminale fragmente von menschlichem serumalbumin.
ATE159297T1 (de) Expression von menschlichen serumalbumin in methylotrophischen hefen
DE69224768D1 (de) Expression von menschlichen Serum-Albuminen in Pichia pastoris
KR920701451A (ko) 인체혈청알부민의 n-말단 단편을 함유하는 융합 단백질
BR8907146A (pt) Amido processavel de maneira termoplastica,assim como processo para a sua obtencao
ATE121781T1 (de) Verwendung von dns-fragmenten, die ein signalpeptid kodieren zur sekretion von reifen proteinen in rekombinanten hefen, expressions- kassetten, transformierte hefen und verfahren zur herstellung dieser proteine.
DK0448704T3 (da) Osteogene anordninger
NO993709L (no) Stabilisert blanding omfattende fibrinogen
DE3580283D1 (de) Biologisch wirksame substanz mit hormonellen eigenschaften, verfahren zu ihrer herstellung und verwendung von histonen fuer medizinische zwecke.
DE3675907D1 (de) Zusammensetzung und methode zur wiederherstellung von knochen.
DE69102651D1 (de) Proteaseresistenter pdgf und dessen verwendungen.
DE68908913D1 (de) Faktor XIII zur Vorbeugung von intraventrikulären Blutungen.
ATE121420T1 (de) Verfahren zur herstellung von 3-(l-pyroglutamyl)- l-thiazolidin-4-carbonsäure-derivaten.
DE59401990D1 (de) Imidazolyl-substituierte Phenylessigsäureprolinamide
NO885231L (no) Peptidstrukturer, immunogener og anvendelse for fertilitetskontroll.
DE69529750D1 (de) Verbesserungen in der herstellung von proteinen in wirtszellen
HUT44609A (en) Process for preparing new polypeptides
DE68923496D1 (de) Verfahren zur Herstellung von motilinähnlichen Polypeptiden und seine Expression.
ATE62693T1 (de) Waermedefibrinogenierung eines ahf-praeparates.
ATE123056T1 (de) Ancrod-proteine, ihre herstellung und verwendung.
KR870004142A (ko) 인터로이킨-2 유도체의 제조방법

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired